mMe: Motivational Monitoring to Enhance Smoking Cessation Among Cancer Patients
NCT ID: NCT05370859
Last Updated: 2024-04-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
25 participants
OBSERVATIONAL
2022-07-18
2024-02-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Motivating a Spectrum of Cancer Patients to Quit Smoking
NCT04914000
Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
NCT06484179
Comprehensive Tobacco Cessation for Cancer Patients and Survivors
NCT05805722
Strategies to Promote Cessation in Smokers Who Are Not Ready To Quit
NCT02905656
Contingency Management to Promote Smoking Abstinence in Cancer Patients
NCT04605458
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mme Study Participants
Participants will complete a baseline survey, 11 weekly surveys, and a follow-up survey at 12 weeks
There is no intervention for this study
There is no intervention or exposure for this study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
There is no intervention for this study
There is no intervention or exposure for this study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Current smoker defined by: Has smoked 100 cigarettes in their lifetime (may be multi-tobacco users as long as they also use combustible cigarettes).
* Any type of cancer (except non-melanoma skin cancer)
* Anticipates receiving any of the following cancer treatments in the 3 months following enrollment: chemotherapy, surgery, immunotherapy, bone marrow or stem cell transplant, hormone therapy, or radiation
* Access to the Internet
Exclusion Criteria
* \< 18 years in age
* Diagnosed with non-melanoma skin cancer
* Not diagnosed with cancer
* Does not anticipate receiving cancer treatments in the 3 months following enrollment
* Has been previously enrolled in an existing Cancer Center Tobacco Treatment Program (TTP)
* Not comfortable reading and responding to questions in English
* No consistent access to the Internet
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Virginia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kara Wiseman, MPH, PhD
Research Assistant Professor of Public Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Virginia Cancer Center and affiliated sites
Charlottesville, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18184
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.